The study, published Jan. 27, compared the outcomes among the first 30 COVID-19 lung transplant patients at Northwestern to those of 72 patients who needed a lung transplant for other reasons, such as chronic end-stage lung disease.
None of the COVID-19 patients developed lung rejection and all were alive at the time the JAMA article was written, according to a Feb. 2 news release.
“This study proves lung transplantation is highly effective and successful in critically-ill COVID-19 patients,” said Ankit Bharat, MD, study author and chief of thoracic surgery at Northwestern Medicine. “We were especially surprised to find that patients with COVID-19 did not develop rejection of the lungs after transplant.”
Still, lung transplant procedures are much more difficult and carry more risks for COVID-19 patients, researchers said, adding that transplant centers should be selective when considering who the best candidates for such procedures are.
Northwestern Medicine surgeons in June 2020 completed the nation’s first lung transplant on a COVID-19 patient.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
